Jon R. Ward

Pigmented epithelioid melanocytoma

Jon R. Ward, Stephen Brady, Hiroomi Tada et al. · International Journal of Dermatology · 2006 · 206 citations

Biopsy Specimen, Tumoral Pathology, Skin Cancer +13

Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor

Jon R. Ward, Lynne Bingle, Heather M. Judge et al. · Thrombosis and Haemostasis · 2005 · 135 citations

The low-toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells

Bruce S. Thompson, Paula M. Chilton, Jon R. Ward et al. · Journal of Leukocyte Biology · 2005 · 132 citations

3-<i>O</i>-Desacyl Monophosphoryl Lipid A Derivatives:  Synthesis and Immunostimulant Activities

David A. Johnson, David S. Keegan, C. Gregory Sowell et al. · Journal of Medicinal Chemistry · 1999 · 92 citations

Inflammation, Biochemistry, Tetanus Toxoid Vaccines +11

Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase.

Qingping Liu, Kristy Fruit, Jon R. Ward et al. · PubMed · 1999 · 87 citations

Macrophage Activation, Immunology, Immune Regulation +21